Dermatitis Herpetiformis Duhring

  • Christian Rose
  • Detlef Zillikens


Celiac Disease Coeliac Disease Bullous Pemphigoid Celiac Disease Patient Tissue Transglutaminase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ackerman AB, Chongchitnant N, Sanchez J, Guo Y, Bennin B, Reichel M, Randall MB (1997) Histologic diagnosis of inflammatory skin diseases, 2nd ed. Williams & Wilkins, Baltimore, pp 271–278Google Scholar
  2. Alexander O’D (1963) The treatment of dermatitis herpetiformis with heparin. Br J Dermatol 75: 289–293PubMedGoogle Scholar
  3. Beutner EH, Baughman RD, Austin BM, Plunkett RW, Binder WL (2000) A case of dermatitis herpetiformis with IgA endomysial antibodies but negative direct immunofluorescent findings. J Am Acad Dermatol 43: 329–332CrossRefPubMedGoogle Scholar
  4. Brow J, Parker F, Weinstein W, Rubin CE (1971) The small intestinal mucosa in dermatitis herpetiformis: severity and distribution of the small intestinal lesion and associated malabsorption. Gastroenterology 60: 355–361PubMedGoogle Scholar
  5. Collin P, Pukkala E, Reunala T (1996) Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Gut 38: 528–530PubMedGoogle Scholar
  6. Cormane RH (1967) Immunofluorescent studies of the skin in lupus erythematosus and other diseases. Pathologica Eur 2: 170–180Google Scholar
  7. Corrao G, Corazza GR, Andreani ML, Torchio P, Valentini RA, Galatola G, Quaglino D, Gasbarrni G, di Orio F (1994) Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut 35: 771–775PubMedGoogle Scholar
  8. Costello M (1940) Dermatitis herpetiformis treated with sulfapyridine. Arch Dermatol Syphilol 41: 134Google Scholar
  9. Chorzelski TP, Jablonska S, Beutner EH, Bear SF, Furey NL (1979) Linear IgA bullous dermatosis. In: Beutner EH, Chorzelski TP, Bear SF (eds) Immunopathology of the skin. 2nd ed. John Wiley & Sons; New York, pp 315–323Google Scholar
  10. Chorzelski TP, Sulej J, Tchorzewska H, Jablonska S, Beutner EH, Kumar V (1983) IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann N Y Acad Sci 4: 325–334Google Scholar
  11. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Med 3: 797–801CrossRefPubMedGoogle Scholar
  12. Dieterich W, Laag E, Schöpper H, Volta U, Ferguson A, Gillett H, Riecken EO, Schuppan D (1998) Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 115: 1317–1321PubMedGoogle Scholar
  13. Dieterich W, Laag E, Bruckner-Tuderman L, Reunala T, Kárpáti S, Zágoni T, Riecken EO, Schuppan D (1999) Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol 113: 133–136CrossRefPubMedGoogle Scholar
  14. Duhring LA (1884) Dermatitis herpetiformis. JAMA 3: 225–229Google Scholar
  15. Ermacora E, Prampolini L, Tribbia G, Pezzoli G, Gelmetti C, Cucchi G, Tettamanti A, Giunta A, Gianotti F (1986) Long-term follow-up of dermatitis herpetiformis in children. J Am Acad Dermatol 15: 23–30Google Scholar
  16. Fraser NG, Kerr NW, Donald D (1973) Oral lesions in dermatitis herpetiformis. Br J Dermatol 89: 439–450PubMedGoogle Scholar
  17. Fry L, Keir P, McMinn RMH, Cowan JD, Hoffbrand AV (1967) Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet II: 729–734CrossRefGoogle Scholar
  18. Fry L, Seah PP, Riches DJ, Hoffbrand AV (1973) Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lancet I: 288–291CrossRefGoogle Scholar
  19. Fry L, Leonard JN, Swain F, Tucker WFG, Haffenden G, Ring N, McMinn RMH (1982) Long-term follow-up of dermatitis herpetiformis with and without dietary gluten withdrawal. Br J Dermatol 107: 631–640PubMedGoogle Scholar
  20. Fry L (1988) Fine points in the management of dermatitis herpetiformis. Semin Dermatol 7: 206–211PubMedGoogle Scholar
  21. Fry L (2002) Dermatitis herpetiformis: problems, progress and prospect. Eur J Dermatol 12: 523–531PubMedGoogle Scholar
  22. Garioch JJ, Lewis HM, Sargent SA, Leonard JN, Fry L (1994) 25 years’ experience of gluten-free diet in the treatment of dermatitis herpetiformis. Br J Dermatol 131: 541–545PubMedGoogle Scholar
  23. Graeber M, Baker BS, Garioch JJ (1993) The role of cytokines in the generation of skin lesions in dermatitis herpetiformis. Br J Dermatol 129: 530–532PubMedGoogle Scholar
  24. Hall MA, Lanchbury JSS, Bolsover WJ, Ciclitira JP (1991) HLA association with dermatitis herpetiformis is accounted for by a cis or transassociated DQ heterodimer. Gut 32: 487–490PubMedGoogle Scholar
  25. Hardman CM, Garioch JJ, Leonard JN, Thomas HJ, Walker MM, Lortan JE, Lister A, Fry L (1997) Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med 337: 1884–1887CrossRefPubMedGoogle Scholar
  26. Hendrix JD, Karen L, Mangum MT, Zone JJ, Gammon WR (1990) Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neutrophils. J Invest Dermatol 94: 667–672CrossRefPubMedGoogle Scholar
  27. Kadunce DP, Meyer LJ, Zone JJ (1989) IgA class antibodies in dermatitis herpetiformis: reaction with tissue antigens. J Invest Dermatol 93: 253–258CrossRefPubMedGoogle Scholar
  28. Kárpáti S, Torok E, Kosnai I (1986) Discrete palmar and plantar symptoms in children with dermatitis herpetiformis Duhring. Cutis 3: 184–187Google Scholar
  29. Kárpáti S, Meurer M, Stolz W, Schrallhammer K, Krieg T, Braun-Falco O (1990) Dermatitis herpetiformis bodies. Arch Dermatol 126: 1469–1474CrossRefPubMedGoogle Scholar
  30. Lear JT, Neary RH, Jones P, Fitzgerald DA, English JS (1997) Risk factors for ischaemic heart disease in patients with dermatitis herpetiformis. J R Soc Med 90: 247–249PubMedGoogle Scholar
  31. Leonard J, Haffenden G, Tucker W, Unsworth J, Swain F, McMinn R, Holborow J, Fry L (1983) Gluten challenge in dermatitis herpetiformis. N Engl J Med 308: 816–819PubMedGoogle Scholar
  32. Lewis HM, Reunala TL, Garioch JJ, Leonard JN, Fry JS, Collin P, Evans D, Fry L (1996) Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 135: 363–367PubMedGoogle Scholar
  33. Olkarinen AL, Reunala T, Zone JJ, Kilstala U, Uitto J (1986) Proteolytic enzymes in blister fluids from patients with dermatitis herpetiformis. Br J Dermatol 114: 295–302PubMedGoogle Scholar
  34. Marks J, Shuster S, Watson AJ (1966) Small bowel changes in dermatitis herpetiformis. Lancet II: 1280–1282CrossRefGoogle Scholar
  35. McFadden JP, Leonard JN, Powles AV, Rutman AJ, Fry L (1989) Sulphamethoxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid. Br J Dermatol 121: 759–762PubMedGoogle Scholar
  36. Mobacken H, Kastrup W, Nilsson L. (1984) Incidence and prevalence of dermatitis herpetiformis in Western Sweden. Acta Derm Venereol 64: 400–404PubMedGoogle Scholar
  37. Prendiville JS, Esterly NB (1991) Childhood dermatits herpetiformis. Clin Dermatol 9: 375–381CrossRefPubMedGoogle Scholar
  38. Raghunath M, Höpfner B, Aeschlimann D, Lüthi U, Meuli M, Altermatt S, Gobet R, Bruckner-Tuderman L, Steinmann B (1996) Cross-linking of the dermo-epidermal junction of skin regenerating from keratinocyte autografts. J Clin Invest 98: 1174–1184PubMedGoogle Scholar
  39. Reunala T, Collin P (1997) Diseases associated with dermatitis herpetiformis. Br J Dermatol 136: 315–318CrossRefPubMedGoogle Scholar
  40. Reunala T, Collin P, Holm K, Pikkarainen P, Miettinen A, Vuolteenaho N, Maki M (1998) Tolerance to oats in dermatitis herpetiformis. Gut 43: 490–493PubMedGoogle Scholar
  41. Rose C, Dieterich W, Bröcker EB, Schuppan D, Zillikens D (1999) Circulating autoantibodies to tissue transglutaminase differentiate patients with dermatitis herpetiformis from those with linear IgA disease. J Am Acad Dermatol 41: 957–961PubMedGoogle Scholar
  42. Rose C, Bröcker EB, Krahl D (2003) Dermatitis herpetiformis with flame figures mimicking an arthropod bite. Am J Dermatopathol 25: 277–278CrossRefPubMedGoogle Scholar
  43. Rütten A, Goos M (1989) Palmoplantar purpura in Duhring’s herpetiform dermatitis. Hautarzt 40: 640–643PubMedGoogle Scholar
  44. Sachs JA, Awad J, McCloskey D, Navarrete C, Festenstein H, Elliot E, Walker-Smith JA, Griffiths CE, Leonard JN, Fry L (1986) Different HLA associated gene combinations contribute to susceptibility for coeliac disease and dermatitis herpetiformis. Gut 27: 515–520PubMedGoogle Scholar
  45. Sárdy M, Odenthal U, Kárpáti S, Paulsson M, Smyth N (1999) Recombinat human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy. Clin Chem 45: 2142–2149PubMedGoogle Scholar
  46. Sárdy M, Kárpáti S, Merkl B, Paulsson M, Smyth N (2002) Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 195: 747–757CrossRefPubMedGoogle Scholar
  47. Schuppan D (2000) Current concepts of celiac disease pathogenesis. Gastroenterology 119: 234–242CrossRefPubMedGoogle Scholar
  48. Seissler J, Borns S, Wohlrab U, Morgenthaler NG, Mothes T, Boehm BO, Scherbaum WA (1999) Antibodies to human tissue transglutaminase measured by radioligand assay: evidence for high diagnostic sensitivity for celiac disease. Horm Metab Res 31: 375–379PubMedGoogle Scholar
  49. Silvers DN, Juhlin EA, Berczeller PH, McSorley J (1980) Treatment of dermatitis herpetiformis with colchicine. Arch Dermatol 116: 1373–1374CrossRefPubMedGoogle Scholar
  50. Shah SAA, Ormerod AD (2000) Dermatitis herpetiformis effectively treated with heparin, tetracycline and nicotinamide. Clin Exp Dermatol 25: 204–205CrossRefPubMedGoogle Scholar
  51. Smith JB, Taylor TB, Zone JJ (1992a) The site of blister formation in dermatitis herpetiformis is within the lamina lucida. J Am Acad Dermatol 27: 209–213PubMedGoogle Scholar
  52. Smith JB, Tulloch JE, Meyer LJ, Zone JJ (1992b) The incidence and prevalence of dermatitis herpetiformis in Utah. Arch Dermatol 128: 1608–1610CrossRefPubMedGoogle Scholar
  53. Sulkanen S, Halttunen T, Laurila K, Kolho KL, Korponay-Szabo IR, Sarnesto A, Savilahti E, Collin P, Mäki M (1998) Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115: 1322–1328PubMedGoogle Scholar
  54. Swerdlow AJ, Whittaker S, Carpenter LM, English JSC (1993) Mortality and cancer incidence in patients with dermatitis herpetiformis: a cohort study. Br J Dermatol 129: 140–144PubMedGoogle Scholar
  55. Tan CC, Sale JE, Brammer C, Irons RP, Freeman JG (1996) A rare case of dermatitis herpetiformis requiring parenteral heparin for long-term control. Dermatology 192: 185–186PubMedGoogle Scholar
  56. Van der Meer JB (1969) Granular deposits of immunoglobulins in the skin of patients with dermatitis herpetiformis. Br J Dermatol 81: 493–503PubMedGoogle Scholar
  57. Ventura A, Magazzu G, Greco L for the SIGEP study group for autoimmune disorders in celiac disease (1999) Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 117: 297–303CrossRefPubMedGoogle Scholar
  58. Warren SJP, Cockerell CJ (2002) Characterization of a subgroup of patients with dermatitis herpetiformis with nonclassical histologic features. Am J Dermatopathol 24: 305–308CrossRefPubMedGoogle Scholar
  59. Zillikens D, Kawahara Y, Ishiko A, Shimizu H, Mayer J, Rank CV, Liu Z, Giudice GJ, Tran HH, Marinkovich MP, Bröcker EB, Hashimoto T (1996) A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol 106: 1333–1336CrossRefPubMedGoogle Scholar
  60. Zemtsov A, Neldner K (1993) Successful treatment of dermatitis herpetiformis with tetracycline and nicotinamide in a patient unable to tolerate dapsone. J Am Acad Dermatol 28: 505–506PubMedGoogle Scholar
  61. Zone JJ, Laurence JM, Peterson MJ (1996) Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol 132: 912–918CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2005

Authors and Affiliations

  • Christian Rose
  • Detlef Zillikens

There are no affiliations available

Personalised recommendations